1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Angiofibroma: new trials by email Literature Review of Angiofibroma trials Research Report on Angiofibroma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Rapamycin to Erase Angiofibromas in TSC Placebo, Rapamycin - Angiofibromas, Tuberous Sclerosis | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 179 | 2012-05-01 | 2020-10-26 |
Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hamartoma (1) · Heredodegenerative Disorders, Nervous System (1) · Malformations of Cortical Development (1) · Malformations of Cortical Development, Group I (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Multiple Primary (1) · Neoplasms, Vascular Tissue (1) · Neoplastic Syndromes, Hereditary (1) · Nervous System Diseases (1) · Nervous System Malformations (1) · Neurocutaneous Syndromes (1)
Sirolimus (1)
The University of Texas Health Science Center, Houston (1)
Australia (1) · United States (1)
Hope Northrup, MD (1) · Mary Kay Koenig, MD (1)